Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2581
-0.0658-20.31%
Post-market: 0.26000.0019+0.74%19:59 EDT
Volume:2.02M
Turnover:572.63K
Market Cap:66.39M
PE:-0.86
High:0.3200
Open:0.3150
Low:0.2500
Close:0.3239
Loading ...

Adaptimmune Therapeutics Plc - Gavin Wood to Step Down as Chief Financial Officer

THOMSON REUTERS
·
19 Dec 2024

Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK

Newsfile
·
19 Dec 2024

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week

MT Newswires Live
·
14 Dec 2024

European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading

MT Newswires Live
·
12 Dec 2024

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live
·
05 Dec 2024

First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)

Newsfile
·
03 Dec 2024

Mizuho Cuts Price Target on Adaptimmune Therapeutics to $1.50 From $3, Keeps Outperform Rating

MT Newswires Live
·
27 Nov 2024

Adaptimmune Therapeutics Plc : Mizuho Cuts Target Price to $1.50 From $3

THOMSON REUTERS
·
27 Nov 2024

European Equities Traded in the US as American Depositary Decline in Tuesday Trading

MT Newswires Live
·
27 Nov 2024

European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week

MT Newswires Live
·
23 Nov 2024

European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading

MT Newswires Live
·
20 Nov 2024

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TIPRANKS
·
19 Nov 2024

Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
18 Nov 2024

Adaptimmune price target lowered to $3 from $4 at Guggenheim

TIPRANKS
·
15 Nov 2024

Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $3 From $4

THOMSON REUTERS
·
15 Nov 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
14 Nov 2024

Scotiabank Remains a Buy on Adaptimmune Therapeutics (ADAP)

TIPRANKS
·
14 Nov 2024

Adaptimmune Therapeutics Plc : H.c. Wainwright Cuts Target Price to $3.5 From $4

THOMSON REUTERS
·
14 Nov 2024

ADAP 3Q24 Earnings Review: Streamlining the Platform; Profitability Inflection Point in 2027

Zacks Small Cap Research
·
14 Nov 2024

Adaptimmune Therapeutics PLC (ADAP) Q3 2024 Earnings Call Highlights: Strategic Restructuring ...

GuruFocus.com
·
14 Nov 2024